
SynapCon GmbH is a digital health technology company focused on accelerating clinical trials for drugs, medical devices, and IVDs through a fully integrated software suite. Their platform combines pre-trial services, clinical trial management, and AI-driven big data analytics to massively increase efficiency, shorten development cycles, and reduce costs, enabling faster access to healthcare globally. The company emphasizes audit-proof, secure, and sustainable clinical trials compliant with international standards such as ISO 14155, ISO 14971, GAMP-5, FDA, EMA, GDPR, and others. Developed in the UK, Germany, and Austria, SynapCon targets biotech, medtech, pharma, and IVD industries with a SaaS business model, supported by public sponsorship from German ministries. With over 30 years of experience, 250+ business partners, and 78 studies across 78 countries, SynapCon is positioned as a modern disruptor of the traditional paper-based clinical trial industry, offering affordable, easy-to-use, and compliant solutions.

SynapCon GmbH is a digital health technology company focused on accelerating clinical trials for drugs, medical devices, and IVDs through a fully integrated software suite. Their platform combines pre-trial services, clinical trial management, and AI-driven big data analytics to massively increase efficiency, shorten development cycles, and reduce costs, enabling faster access to healthcare globally. The company emphasizes audit-proof, secure, and sustainable clinical trials compliant with international standards such as ISO 14155, ISO 14971, GAMP-5, FDA, EMA, GDPR, and others. Developed in the UK, Germany, and Austria, SynapCon targets biotech, medtech, pharma, and IVD industries with a SaaS business model, supported by public sponsorship from German ministries. With over 30 years of experience, 250+ business partners, and 78 studies across 78 countries, SynapCon is positioned as a modern disruptor of the traditional paper-based clinical trial industry, offering affordable, easy-to-use, and compliant solutions.
Founded: May 2021
Headquarters: Frankfurt am Main, Germany
Product: EasyClin suite — validated cloud platform for clinical trial management and compliance
CEO / Founder: Sven Engel
Public sponsorship: Supported by German ministries (stated)
Clinical trial management, regulatory compliance, and trial acceleration for drugs, medical devices, and IVDs.
2021
Digital Health / Clinical Trials Software
Crunchbase lists a Seed round in March 2023; amount obfuscated in available data.